Feds Would Develop ‘Impairment Standards’ For Marijuana And Other Drugs Under New Bipartisan Transportation Bill In Congress
Indiana Governor Touts Medical Marijuana’s Benefits For Veterans, Saying He Hopes Opposition From GOP Lawmakers ‘Softens’
Truckers And Pilots Still Can’t Use Medical Marijuana Even Though Trump Reclassified It, Transportation Department Says
For Psychedelics, The Pharmaceutical And Natural Medicine Pathways Are Both Legitimate—And Compatible (Op-Ed)
Ohio Marijuana And Hemp Referendum Campaign Failed To Pay For Some Signatures As Promised, Petitioners Say
Marijuana Can Play A Role In Combating Obesity, Contrary To Stereotypes About Lazy Stoners With The Munchies, New Federally Funded Study Suggests
CBD Holds Potential As An ‘Anticancer Agent’ For Dogs, New Scientific Review Concludes
Medical Marijuana Helps Pain Patients Reduce Use Of Opioids, New Study Shows
More Older Adults Are Using Marijuana As An Alternative To Pharmaceuticals, Federally Funded Study From American Medical Association Shows
A Single Dose Of Psilocybin Appears To Safely Treat Cocaine Addiction, New Study Published By American Medical Association Study Shows
Politicians And Major Brands Celebrate Cannabis Culture On 4/20
Woody Harrelson And Bill Maher Complain That Marijuana Taxes Are Too High While Smoking Joints At The Dispensary They Own Together
WNBA Offers To End Marijuana Testing For Women’s Basketball Players As Part Of Reported Deal With Union
DEA Promotes Anti-Marijuana PSA Contest Inviting Students To Warn Peers About THC Dangers On 4/20
Largest Entertainment Arena In US Partners With Cannabis Businesses To Sell THC Drinks At Concerts And Live Events
Target Is Launching Hemp THC Drink Sales In Three Of The U.S.’s Most Populous States
Target Expands Involvement In Hemp THC Drinks Market With 72 New Licenses In Minnesota
Marijuana Sales Are Rising And Alcohol Is On The Decline As Consumer Preferences Evolve, Government Data In Canada Shows
Feds Deny Snoop Dogg Request To Trademark ‘Smoke Weed Everyday’ Because Marijuana Is Illegal And Song Lyric Is Too Popular
Marijuana Kiosks For Seniors Are Coming To Independent Living Communities Across Arizona
Marijuana & alcohol industries oppose hemp bill, congressman says (Newsletter: May 18, 2026)
Amendment to let military vets get medical cannabis approved at VA passes (Newsletter: May 15, 2026)
Lawmakers push cannabis reform on Capitol Hill (Newsletter: May 14, 2026)
Congress wants crackdown on unregulated cannabis products (Newsletter: May 13, 2026)
DEA launching new cannabis business registration applications (Newsletter: May 12, 2026)
Published
on
By
Bipartisan leaders of a key House committee have released the text of transportation legislation containing provisions to require federal officials to study the issue of driving of driving under the influence of marijuana and other drugs and propose “evidence-based impairment standards.”
Reps. Sam Graves (R-MO) and Rick Larsen (D-WA), who are, respectively, the chair and ranking member of the House Transportation and Infrastructure Committee, announced the new bill on Sunday.
The 1,005-page “Building Unrivaled Infrastructure and Long-term Development (BUILD) for America’s 250th Act” covers broad areas of transportation, including roads, bridges, rail and highway programs.
The proposal’s section on drug issues would require the secretary of transportation to collaborate with the heads of other relevant federal agencies to “study the effect that marijuana and polysubstance impairment has on driving” and to analyze measures for detecting and reducing impaired driving.
The federal officials would then need to “propose evidence-based impairment standards for marijuana or polysubstance use,” and the transportation secretary would need to provide Congress with a report describing progress on the effort.
Under a separate provision of the legislation, the secretary would be directed to establish a national drug involved crash data collection system.
Its duties would be to:
‘‘(A) collect standardized toxicology data from States for fatal and serious injury crashes;
(B) link crash data with medical, coroner, hospital, and emergency medical services records; and
(C) provide model protocols for specimen collection, testing, and reporting.”
Under that system, the Department of Transportation (DOT) could award grants to states assist with launching pilot programs for enhanced data collection and to support toxicology labs, specimen collection, training, data systems and data linkage.
In order to protect people’s privacy, the data would need to be “deidentified” before it is made publicly available, including through a report the transportation secretary would be required to provide to Congress that would “analyze trends, substance types, and geographic patterns collected under the system.”
The bill would require the department to spend $110 million to support the effort from Fiscal Years 2027-2031.
Additionally, the legislation would direct administrator of the National Highway Traffic Safety Administration (NHTSA) to submit a report to Congress on the status of the collaborative research effort to advance impaired driving prevention technology.
The announcement of the new bipartisan bill with impaired driving provisions comes days after DOT issued new guidance saying that truck drivers, airline pilots and other safety-sensitive workers still cannot use medical marijuana without punishment despite the Trump administration’s move to reschedule it.
“Marijuana use is not compatible with safety-sensitive functions,” the agency said on Friday.
Medical review officers (MROs) who receive drug test results indicating cannabis consumption cannot deem them to be negative for illegal substance use, even when an employee says it was the result of state-licensed medical marijuana, the department said.
“Currently, there is no instance when the MRO could verify a laboratory-confirmed marijuana positive drug test result as ‘negative’ when an employee claims the positive was caused by a State licensed marijuana product,” DOT said, explaining that even after rescheduling, medical marijuana dispensed in accordance with state law “does not constitute” a drug that has been approved by the Food and Drug Administration (FDA).
Last October, Transportation Secretary Sean Duffy suggested President Donald Trump was “getting pressure” to reschedule cannabis—arguing that marijuana is “really addictive” and saying that policy reform around the issue sends a “dangerous” message.
“At a time when culture is pushing and celebrating the use of marijuana, we’re not talking about the risk,” Duffy said.
Tom Angell is the editor of Marijuana Moment. A 25-year veteran in the cannabis and drug law reform movement, he covers the policy, politics, science and culture of marijuana, psychedelics and other substances. He previously reported for Forbes, Marijuana.com and MassRoots, and was given the Hunter S. Thompson Media Award by NORML and has been named Journalist of the Year by Americans for Safe Access. As an activist, Tom founded the nonprofit Marijuana Majority and handled media relations, campaigns and lobbying for Law Enforcement Against Prohibition and Students for Sensible Drug Policy.
Add Marijuana Moment as a preferred source on Google.
All the cannabis news you need, all in one place. Copyright © 2017-2026 Marijuana Moment LLC ® and Tom Angell
Feds Would Develop 'Impairment Standards' For Marijuana And Other Drugs Under New Bipartisan Transportation Bill In Congress – Marijuana Moment
Leave a Comment
